Dr Satheesh Kumar Nanjappan
Associate Professor
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH KOLKATA
West Bengal
Expertise:
Pharmacology and Pharmacy
59
Publications
5
Projects
420
Scopus Citations
1156
CrossRef
15 Years 4 Months Total Experience
Scopus
420
Citations
13
h-index
CrossRef
1,156
Citations
18
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Indian Society of Mass Spectrometry Young Scientist Award
2019
Indian Society of Mass Spectrometry
Associate Fellow of Telangana Academy of Science (TAS
2016
Telangana Academy of Science
IDMA-Best Research Award in Pharmaceutical Analysis
2016
Indian Drug Manufacturers' Association
Young Pharmaceutical Analyst Award
2014
Indian Drug Manufacturers' Association (IDMA)
UK-India Newton Bhabha Fund Researcher Links Workshop
2019
British Council
Start up research grants scheme for Young Scientists
2013
DST
Community & Membership
No Data Found
There is currently nothing to display here.
Indian Society For Mass Spectrometry
LifeAssociation of Pharmaceutical Teachers of India
LifePersonal Details
Doctor of Philosophy
2010
National Institute of Cholera and Enteric Diseases
Master of Pharmacy
2006
N/A
Bachelor of Pharmacy
2004
N/A
Associate Professor
Oct 2020 – Present
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH KOLKATA
Assistant Professor
Dec 2012 – Feb 2020
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad
| Department of Pharmaceutical Analysis
Lecturer
Oct 2010 – Dec 2012
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad
| Department of Pharmaceutical Analysis
Medical and Health Sciences
Scholarly Work
Understanding the impact of drug-herbal dietary supplements pharmacokinetic interactions: Integrated transcriptomics analysis to study the key metabolism, pathways, and safety evaluation
OtherEvaluation of Cytochrome P450 mediated herb drug interaction of some herbal medicinal products using LCMS
CompletedExperimental Bioassay and Pharmacokinetic evaluation of Anticholinesterase Pharmaceuticals from Natural Origin for the Treatment of Alzheimer’s Disease
CompletedTargeting adipocyte differentiation as a pathway for the treatment of obesity: implications in the development of obesity associated insulin resistance
CompletedHerb - Drug Interactions: Transport and Metabolism of herbal slimming agents in the presence of lipase inhibitors, antihyperglycemic agents, HMG-CoA reductase inhibitor and hypocholesterolemic agent
CompletedBiological and pharmaceutical investigations of anti-diabetic drugs inhibiting DPP-4 enzyme by liquid chromatography-tandem mass spectrometry and other modern analytical techniques
Identification of degradation products and metabolites of some selected drugs by LC-MS and in vitro cytotoxicity evaluation of isolated degradation products
Bioanalytical Method Development and Pharmacokinetic Interaction Studies of Selected Drugs Using Liquid Chromatography-Mass Spectrometry
Use of high resolution LC-MS, NMR analysis for characterization of degradation products and metabolites of selected drugs: in vitro cytotoxicity and molecular docking studies of isolated degradation products
Herb-Drug interactions: Transport and metabolism of antihyperglycemic agents and HMG-CoA reductase inhibitors in the presence of herbal slimming agents
Evaluation of Pharmacokinetic interaction and Metabolism of Selected drugs Using Liquid Chromatography-Mass Spectrometry
Adipogenesis modulators from Indian medicinal plants acting through PPAR-γ in the treatment of Obesity
No Data Found
There is currently nothing to display here.
Scholarly Publications
Study of Forced Degradation Behaviour of Brinzolamide Using LC–ESI–Q-TOF and In Silico Toxicity Prediction
Liquid chromatography-mass spectrometry (LC-MS): Approaches to adulterant detection in herbal products
10.1007/978-981-10-1085-9_3
Crossref: 7
Spices: Potential therapeutics for alzheimer’s disease
10.1007/978-3-319-28383-8_4
Crossref: 5
QBD based RP-HPLC method for screening and analysis of telapravir and 7 other antiretroviral agents
A stability-indicating reversed-phase high-performance liquid chromatography method for ambrisentan: An endothelin receptor antagonist
10.1093/chromsci/bmt138
Crossref: 7
Compatibility study between sitagliptin and pharmaceutical excipients used in solid dosage forms
10.1007/s10973-013-3329-3
Crossref: 28
Development of validated stability indicating assay method for simultaneous estimation of metformin hydrochloride and vildagliptin by RP-HPLC
10.1055/s-0033-1354373
Crossref: 12
Liquid chromatography/electrospray ionisation tandem mass spectrometric study of sitagliptin and its stressed degradation products
10.1055/s-0034-1370915
Crossref: 6
Showing 1 to 8 of 59 publications